Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume.

Michael E Chen1, Dennis Johnston, Adriana O Reyes

  • 1Department of Urology, Kaiser Permanente Medical Group, Denver, Colorado, USA.

The American Journal of Surgical Pathology
|September 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer.

European urology·2026
Same author

Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment.

Prostate cancer and prostatic diseases·2025
Same author

KDM4A promotes NEPC progression through regulation of MYC expression.

Cancer letters·2025
Same author

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.

European urology·2025
Same author

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis.

European urology oncology·2025
Same author

Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists.

Histopathology·2025

A new formula using tumor length, width, and cross-section measurements accurately estimates prostate tumor volume. This method simplifies volume assessment, improving prediction of clinical significance and patient outcomes.

Area of Science:

  • Uropathology
  • Surgical Pathology
  • Oncology

Background:

  • Prostate tumor volume is a key predictor of clinical significance and patient outcomes.
  • Current methods for determining prostate tumor volume, like computerized planimetry, are labor-intensive and time-consuming.

Purpose of the Study:

  • To develop and validate a straightforward formula for estimating prostate tumor volume using readily available measurements.
  • To assess the accuracy of this new estimation method in classifying tumor significance.

Main Methods:

  • A formula was derived from 1091 tumor foci in 365 radical prostatectomy specimens (evaluation group).
  • The formula, 0.4 x Length x Width x (Cross Sections x Sectional Thickness), was validated on a separate set of specimens (validation group).
  • Accuracy was tested for classifying tumors as insignificant (<=0.5 cm3) or significant (>0.5 cm3) and into a five-category scheme.

Related Experiment Videos

Main Results:

  • The derived three-dimensional volume estimation formula accurately classified tumors into significant and insignificant categories in 94.0% of cases.
  • Classification into a five-category tumor volume scheme achieved 85.8% accuracy.
  • These accuracy rates surpassed those of other existing methods.

Conclusions:

  • The developed three-dimensional volume estimation formula provides an accurate and efficient method for assessing prostate tumor volume.
  • This straightforward approach can aid in better predicting prostate cancer significance and patient outcomes.
  • The method offers a practical alternative to labor-intensive techniques for routine pathology assessment.